Other new products are in development or awaiting approval. The Ferring UK headquarters is in Langley, Berkshire, where there are both marketing and clinical functions. Ferring works closely with the Society for Endocrinology and the Pituitary Foundation to identify how best to support both healthcare professionals and patients in this area. The Beaufour Ipsen Group has a history of successful discovery, with a continued commitment to research and development in a variety of therapeutic areas. These include endocrinology, oncology, neurobiology, gastroenterology and haematology.
Further uses are currently under development.
Ipsen is a major sponsor of Society meetings. Novartis Pharmaceuticals UK Ltd Novartis is a global leader in the discovery, development, manufacture and marketing of innovative medicines. Novartis has a broad range of products. This range is supported by one of the most promising sets of new products currently in development in the pharmaceutical industry, which will deliver innovation in asthma, IBS and diabetes. In the UK alone Novartis is spending 1 million a week on research into new treatments.